Firefly Neuroscience, Inc.
AIFF
$1.08
$0.000.00%
NASDAQ
| 06/30/2026 | 03/31/2026 | 12/31/2025 | 09/30/2025 | 06/30/2025 | |
|---|---|---|---|---|---|
| Net Income | 60.12% | 59.78% | -90.08% | -173.31% | -455.24% |
| Total Depreciation and Amortization | 134.29% | 416.13% | 1,016.67% | 1,225.00% | 1,650.00% |
| Total Amortization of Deferred Charges | -30.91% | -30.91% | -30.91% | -- | -- |
| Total Other Non-Cash Items | -85.17% | -86.01% | 234.77% | 399.63% | 5,671.59% |
| Change in Net Operating Assets | 70.34% | -979.78% | -365.62% | 66.34% | -708.90% |
| Cash from Operations | 19.07% | -3.87% | -33.13% | -39.65% | -136.40% |
| Capital Expenditure | -102.91% | -15.48% | 13.51% | -172.06% | -60.94% |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | 100.00% | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -- | -- | -- | 100.56% | 87.22% |
| Cash from Investing | 91.78% | -619.26% | -421.59% | -222.87% | -264.47% |
| Total Debt Issued | 29.46% | 29.46% | 29.46% | -- | -- |
| Total Debt Repaid | -- | -- | -- | -- | -- |
| Issuance of Common Stock | -35.01% | -76.01% | 157.36% | 27.45% | 250.62% |
| Repurchase of Common Stock | -2,739.51% | -2,739.51% | -2,739.51% | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | 60.03% |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -- | -- | -- | -- | -- |
| Cash from Financing | -37.24% | -75.96% | 84.46% | 101.54% | 283.73% |
| Foreign Exchange rate Adjustments | -- | -- | -- | -- | -- |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | -40.50% | -181.17% | 381.38% | 818.40% | 50,445.45% |